Press release
Pre-Eclampsia Pipeline Report 2023: What You Need to Know
Pre-Eclampsia Pipeline
DelveInsight's 'Pre-Eclampsia Pipeline Insight 2023' report provides comprehensive global coverage of available, marketed, and pipeline Pre-Eclampsia therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the Pre-Eclampsia pipeline domain.
For Pre-Eclampsia emerging drugs, the Pre-Eclampsia pipeline analysis report provides a 360° view of the therapeutics landscape by development point, product type, route of administration, molecule type, and MOA. The pipeline research covers business opportunities, challenges, future partnerships, strong competitors, and growth strategies.
Request for sample page @ https://www.delveinsight.com/report-store/pre-eclampsia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Key Takeaways from the Pre-Eclampsia Pipeline Report
• Pre-Eclampsia Companies across the globe are diligently working toward developing novel Pre-Eclampsia treatment therapies with a considerable amount of success over the years.
• Leading Pre-Eclampsia companies developing novel drug candidates to improve the Pre-Eclampsia treatment landscape include Kyowa Kirin Co., Ltd, Pharming Group, Amag Pharmaceuticals, MirZyme, Evergreen Therapeutics, Dilafor, and others.
• Promising Pre-Eclampsia pipeline therapies in various stages of development include KW3357, rhC1INH protein replacement therapy, siRNA therapy, C103, GMA312, Tafoxiparin, EG-101, and others.
Request a sample and discover the recent breakthroughs happening Pre-Eclampsia pipeline landscape in @ https://www.delveinsight.com/sample-request/pre-eclampsia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Pre-Eclampsia Overview
Pre-Eclampsia is a pregnancy complication marked by high blood pressure and signs of organ damage, most commonly the liver and kidneys. Pre-Eclampsia is a pregnancy condition characterized by hypertension (high blood pressure) and proteinuria (the presence of protein in your urine). It usually appears during the third trimester. The condition affects between 5% and 8% of pregnancies and has serious health consequences for mothers and babies. There is no single cause, but genetic factors and blood vessel problems are two possibilities. Pre-Eclampsia, if left untreated, can cause serious - even fatal - complications for both mother and baby.
Pre-Eclampsia Pipeline Analysis: Drug Profile
Tafoxiparin: Dilafor
Tafoxiparin, a proprietary heparan sulfate mimetic, has been shown in preclinical and clinical data to supplement and fulfill the role of heparan sulfate, which is required for optimal oxytocin effectiveness. Tafoxiparin's mechanism of action has been supported by preclinical experiments and clinical studies when used in conjunction with oxytocin in current clinical practice. Tafoxiparin can improve uterine contractions and may promote cervical softening, potentially lowering the incidence of protracted labor and its associated complications. The drug is currently in Phase III development for the treatment of preeclampsia.
KW3357: Kyowa Kirin Co., Ltd.
KW-3357 is an antithrombin (AT) drug developed using recombinant DNA and sugar-chain control technology. It is a recombinant AT preparation with the same amino acid sequence and sugar chain structure as human natural AT. AT inhibits blood coagulation by forming a complex with the proteolytic enzyme's coagulation factor. Since July 2015, KW-3357 has been approved in Japan for treating thrombophilia due to congenital AT deficiency (CAD) and disseminated intravascular coagulation (DIC) and is marketed under the brand name ACOALAN. Kyowan Kirin Co., Ltd is currently developing KW3357 in collaboration with Japan Blood Products Organization for Preeclampsia.
Pre-Eclampsia Pipeline Therapies and Key Companies
• KW3357: Kyowa Kirin Co., Ltd.
• rhC1INH protein replacement therapy: Pharming Group
• Tafoxiparin: Dilafor
• EG-101: Evergreen Therapeutics
• Preeclampsia Research Project: MirZyme
• siRNA therapy: Comanche Biopharma
• C 103: Vicore Pharma
• GMA 312: Gmax Biopharm
Learn more about the Pre-Eclampsia emerging pipeline therapies @ https://www.delveinsight.com/sample-request/pre-eclampsia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Pre-Eclampsia Pipeline Therapeutics Assessment
By Product Type
• Monotherapy
• Combination Therapy
By Stage
• Discovery
• Pre-Clinical
• Phase I
• Phase II
• Phase III
• Pre-registration
By Route of Administration
• Subcutaneous
• Intravenous
• Oral
By Molecule Type
• Replacement Therapy
• Physiological Saline
• Antihypertensive
DelveInsight's Pre-Eclampsia pipeline Report covers around 5+ products under different phases of clinical development like-
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Pre-Eclampsia Pipeline Analysis:
The Pre-Eclampsia pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Pre-Eclampsia with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Pre-Eclampsia Treatment.
• Pre-Eclampsia key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Pre-Eclampsia Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Pre-Eclampsia market.
Download Sample PDF Report to know more about Pre-Eclampsia drugs and therapies@ https://www.delveinsight.com/sample-request/pre-eclampsia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Scope of the Pre-Eclampsia Pipeline Report
• Coverage: Global
• Key Pre-Eclampsia Companies: Kyowa Kirin Co., Ltd, Pharming Group (AMS: PHARM), Amag Pharmaceuticals, MirZyme, Evergreen Therapeutics, Dilafor, and others.
• Key Pre-Eclampsia Pipeline Therapies: KW3357, rhC1INH protein replacement therapy, siRNA therapy, C103, GMA312, Tafoxiparin, EG-101, and others.
Dive deep into rich insights for Pre-Eclampsia emerging therapies and assessment; visit @ https://www.delveinsight.com/report-store/pre-eclampsia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents
1.Introduction
2.Pre-Eclampsia Executive Summary
3.Pre-Eclampsia Overview
4.Pre-Eclampsia Pipeline Therapeutics
5.Pre-Eclampsia Pipeline: Late Stage Products (Phase III)
6.Pre-Eclampsia Pipeline: Mid Stage Products (Phase II)
7.Pre-Eclampsia Pipeline: Early Stage Products (Phase I/II)
8.Pre-Eclampsia Pipeline: Preclinical Stage Products
9.Pre-Eclampsia Pipeline: Discovery Stage Products
10.Pre-Eclampsia Pipeline Therapeutic Assessment
11.Pre-Eclampsia Pipeline: Inactive Products
12.Collaborations Assessment- Licensing / Partnering / Funding
13.Unmet Needs
14.Market Drivers and Barriers
15.Appendix
16.About DelveInsight
For further information on the Pre-Eclampsia current pipeline therapeutics, reach out @ @ https://www.delveinsight.com/sample-request/pre-eclampsia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Trending Reports:
• Anaphylaxis Market: https://www.delveinsight.com/report-store/anaphylaxis-market
• Aortic Stenosis Market: https://www.delveinsight.com/report-store/aortic-stenosis-market
• Cluster Headaches Market: https://www.delveinsight.com/report-store/cluster-headache-market
• Familial Primary Pulmonary Hypertension Market: https://www.delveinsight.com/report-store/familial-primary-pulmonary-hypertension-market
• Hpv-induced Cancers Market: https://www.delveinsight.com/report-store/hpv-induced-cancers-market
• Meningioma Market: https://www.delveinsight.com/report-store/meningioma-market
• Optic Neuritis Market: https://www.delveinsight.com/report-store/optic-neuritis-market
• Partial Seizure Market: https://www.delveinsight.com/report-store/partial-seizure-market
• Progressive Multifocal Leukoencephalopathy Market: https://www.delveinsight.com/report-store/progressive-multifocal-leukoencephalopathy-market
• Rhino Conjunctivitis Market: https://www.delveinsight.com/report-store/rhino-conjunctivitis-market
• Thymic Carcinoma Market: https://www.delveinsight.com/report-store/thymic-carcinoma-market
• Pulse Oximeters Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Chronic Lymphocytic Leukemia Market: https://www.delveinsight.com/report-store/relapsed-chronic-lymphocytic-leukemia-cll-market
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Aesthetic Implants Market: https://www.delveinsight.com/report-store/aesthetic-implants-market
• Multiple Myeloma Market: https://www.delveinsight.com/report-store/multiple-myeloma-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Lewy Body Dementia Market: https://www.delveinsight.com/report-store/lewy-body-dementia-market
• Alopecia Market: https://www.delveinsight.com/report-store/alopecia-market
• Neurostimulation Devices Market: https://www.delveinsight.com/report-store/neurostimulation-devices-market
• Pruritus Market: https://www.delveinsight.com/report-store/pruritus-market
• Eczema Market: https://www.delveinsight.com/report-store/eczema-market
• Concussions Market Size: https://www.delveinsight.com/report-store/concussions-market
• Neurovascular Devices Market: https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market
• Human Papilomavirus Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market
• Blood Gas And Electrolyte Analyzers Market: https://www.delveinsight.com/report-store/blood-gas-and-electrolyte-analyzers-market
• Actinic Keratosis Market: https://www.delveinsight.com/report-store/actinic-keratosis-market
• Alzheimer Disease Market: https://www.delveinsight.com/report-store/alzheimers-disease-ad-market
• Chemotherapy Induced Thrombocytopenia Market: https://www.delveinsight.com/report-store/chemotherapy-induced-thrombocytopenia-market-size
• Foot And Ankle Devices Market: https://www.delveinsight.com/report-store/foot-and-ankle-devices-market
• Parkinson's Disease Market: https://www.delveinsight.com/report-store/parkinsons-disease-market-size-analysis-treatment
• Ventilator Market: https://www.delveinsight.com/report-store/ventilators-market
Contact Us:
Ankit Nigam
Assistant Manager Marketing
info@delveinsight.com
https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pre-Eclampsia Pipeline Report 2023: What You Need to Know here
News-ID: 3282054 • Views: …
More Releases from DelveInsight Business Research
DelveInsight Unveils Comprehensive Epidemiology Assessment of Cutaneous Squamous …
DelveInsight, a global leader in healthcare research and analytics, announces the release of its in-depth Cutaneous Squamous Cell Carcinoma (cSCC) Epidemiology Assessment, providing unparalleled insights into the prevalence of cSCC among solid organ transplant recipients across 15 countries, including the United States, key European nations, and select countries in the Asia-Pacific (APAC) region.
The newly released assessment delivers country-specific epidemiological insights aimed at guiding strategic decision-making for pharmaceutical companies, healthcare providers,…
Unlocking Market Potential: DelveInsight's Comprehensive Patent Foramen Ovale (P …
DelveInsight's Market Size & Forecast Assessment Provides Data-Driven Insights for Patient-Centric Market Expansion Strategies
DelveInsight, a leading healthcare market research and consulting firm, has released an in-depth case study highlighting its latest assessment of the Patent Foramen Ovale (PFO) Device Market across the European Union. This strategic market intelligence report provides a holistic understanding of the patient population, device market size, competitor landscape, and reimbursement scenario, equipping medical device companies with…
Global Chronic Obstructive Pulmonary Disease Treatment Devices Market Poised for …
The Chronic Obstructive Pulmonary Disease (COPD) Treatment Devices Market is set for strong expansion, projected to grow at a CAGR of 6.35% from 2025 to 2032, according to recent industry findings. This growth is primarily fueled by the increasing global prevalence of COPD, escalating exposure to tobacco smoke and air pollution, expanding screening programs, and the rapid development of next-generation respiratory devices such as portable nebulizers and smart inhalers.
The global…
CD40 Pipeline 2025: FDA Approvals and Clinical Trials Landscape with MOA and ROA …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, CD40 pipeline constitutes key companies continuously working towards developing CD40 treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"CD40 Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the CD40 Market.
The CD40 Pipeline report embraces in-depth commercial and…
More Releases for Market:
Sorbitol Market Forecast, Sorbitol Market Analysis, Sorbitol Market Growth, Sorb …
The Sorbitol Market has been fragmented based on the productivity of several companies; therefore, each segment and its sub-segments are analyzed in the research report. Furthermore, the report offers 360 views on historical and upcoming growth based on volume, value, production, and consumption. Moreover, it classifies depend on sub-segments, key segments as per the significant regions and offers an in-depth analysis on the competitive edge of the market. This report…
Esterquats Market, Esterquats Market Size, Esterquats Market Share, Esterquats M …
The "Esterquats Market" is a dynamic and rapidly evolving sector, with significant advancements and growth anticipated by 2031. Comprehensive market research reveals a detailed analysis of market size, share, and trends, providing valuable insights into its expansion.
This report delves into segmentation and definition, offering a clear understanding of market components and drivers. Employing SWOT and PESTEL analyses, the study evaluates the market's strengths, weaknesses, opportunities, and threats, alongside political,…
Syringe and Needle Market Size, Market Share, Market Trends, Market Analysis, Ma …
Market Overview:
The global syringe and needle market is a critical component of the healthcare industry, serving as indispensable tools for administering medications, vaccines, and drawing blood samples. This market is characterized by a diverse range of products catering to various medical needs, including disposable syringes, safety syringes, insulin syringes, hypodermic needles, and more. This article provides an in-depth analysis of the syringe and needle market, focusing on its market overview,…
India Tractor Market, Tractor Industry, Market Revenue, Market Growth Analysis, …
How Is India Tractor Market Positioned?
In India two-third population is engaged in Agriculture. Tractors form an essential part of this sector. They bring the required efficiency and productivity country needs in its agricultural activity to compete on the international level. The Indian tractor Industry has made preponderant improvement in production capacity and in terms of production volumes. The industry has been successful in indigenization of the technology. The volume growth…
Global Optical Interconnects Market, Market Size, Market Shares, Market Growth A …
In integrated circuits, optical interconnects majorly refers to a system of transmitting signals from one fragment of an integrated circuit to another part which is using light. Optical interconnects have been in high demand due to the high latency and power consumption incurred by conventional metal interconnects in conveying electrical signals over long distances, such as in interconnects classed as global interconnects.
The International Technology Roadmap for Semiconductors (ITRS) has emphasized…
Global Cash Registers Market, Market Growth Analysis, Market Revenue, Market Out …
A cash register or automatic money handling system is a motorized or electric device for registration and calculating dealings at a point of sale. It is typically devoted to a drawer for storage cash and additional valuables. A modern cash register is generally attached to a printer which can print out incomes for record-keeping determinations. The electronics cash register delivers numerous features likes mall price and informal admittance. The rising acceptance of electronic cash register by…
